CurrentBlue Cross Blue Shield - IllinoisPolicy CPCPLAB018

Helicobacter pylori Testing

Defines reimbursement criteria for diagnostic and test-of-eradication H. pylori testing (urea breath test, stool antigen, biopsy-based tests, susceptibility testing) across BCBSIL products; applies to providers submitting claims for covered members.

Policy Summary

PayerBlue Cross Blue Shield - Illinois

PolicyHelicobacter pylori Testing

Policy CodePolicy CPCPLAB018

Change TypeNo material change

Effective DateSep 5, 2025

Next Review Date

Key ActionProviders must submit accurate documentation and use valid code combinations; claims are subject to review and may require additional documentation upon request.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

20+example codes

>=4 wkspost-treatment interval

11 itemsadult indications

18+/<18age rules

Coverage Criteria for H. pylori Testing

Main coverage criteria

Policy Summary

PayerBlue Cross Blue Shield - Illinois

PolicyHelicobacter pylori Testing

Policy CodePolicy CPCPLAB018

Change TypeNo material change

Effective DateSep 5, 2025

Next Review Date

Key ActionProviders must submit accurate documentation and use valid code combinations; claims are subject to review and may require additional documentation upon request.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

ANY of the following

ALL of the following
- Dyspepsia (see Note 1).
- Active peptic ulcer disease.
- Past peptic ulcer disease with recurrent symptoms.
- Low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
- History of resection of early gastric cancer.
- Gastric intestinal metaplasia.
- Initiating chronic treatment with, or currently on long-term, aspirin or a non-steroidal anti-inflammatory drug.
- Unexplained iron deficiency anemia.
- Idiopathic thrombocytopenic purpura.
- Family history of gastric cancer.
- First-generation immigrants from high-prevalence areas.

ANY of the following

Biopsy-based endoscopic histology PLUS either a rapid urease test OR culture with susceptibility testing may be reimbursable to diagnose H. pylori for individuals >=18 who are undergoing endoscopic examination or who have alarm symptoms.

ANY of the following

ALL of the following
- Gastric or duodenal ulcers or erosions.
- Family history of gastric cancer.

ANY of the following

Biopsy-based endoscopic histology PLUS either a rapid urease test OR culture with susceptibility testing may be reimbursable to diagnose H. pylori in children <18 with refractory iron deficiency anemia.

ANY of the following

Urea breath test OR stool antigen to confirm eradication may be reimbursable for any individual who tested positive for H. pylori when performed at least 4 weeks post-treatment.

ANY of the following

For refractory H. pylori infection, susceptibility testing (culture or nucleic acid-based) may be reimbursable.

ANY of the following

Urea breath test OR stool antigen is not reimbursable for asymptomatic individuals of all ages.
Urea breath test OR stool antigen is not reimbursable for adults (>=18) with typical GERD symptoms (heartburn, regurgitation) who do not have a history of peptic ulcer disease.
Serologic testing for H. pylori is not reimbursable for individuals of any age.
In children (<18), biopsy-based endoscopic histology PLUS rapid urease test or culture with susceptibility testing is not reimbursable for: functional abdominal pain; as part of initial investigation of iron deficiency anemia; or when investigating short stature.
Any diagnostic testing (urea breath test, stool antigen, or biopsy-based testing) is not reimbursable when there has been recent use of antibiotics, proton pump inhibitors, or bismuth.

Documentation, Claims, and Review Requirements

Documentation Required

Documentation and claim review — submit accurate documentation and valid codes; claims may require additional documentation

Providers must submit accurate documentation of services performed and use valid HIPAA-approved code combinations when filing claims. Claims are subject to code edit protocols and may be reviewed against benefit coverage, provider contracts, medical policies, coding policies, and coding software logic; upon request providers should submit additional documentation.

Submit claims using valid code combinations from HIPAA-approved code sets (CPT, HCPCS, ICD-10, NDC, DRG guidelines, CCI edits).
Code claims appropriately per industry-standard coding guidelines (Uniform Billing, AMA CPT Assistant, CMS manuals).
Be prepared to provide additional documentation on request to support medical necessity and coding.

Key Definitions

inv-04: Dyspepsia — definition and common symptom examples

DefinitionDyspepsia: bothersome upper abdominal symptoms often meal related; predominant symptoms include postprandial fullness (bloating), early satiety, or epigastric pain or burning; pain is not required for diagnosis.

Postprandial fullness (bloating)Fullness or bloating after meals is a predominant symptom, especially in chronic dyspepsia where it is more common than pain.

Early satietyInability to finish a normal-sized meal because of postprandial discomfort; a common presenting symptom.

Epigastric pain or burningPain or burning in the epigastric region that may or may not be related to meals; less common in chronic dyspepsia compared with fullness or satiety.

inv-05: Alarm features — list of alarm features of dyspepsia (vomiting, GI bleeding, unexplained iron deficiency, weight loss)

Alarm features — vomitingPersistent or recurrent vomiting is considered an alarm feature warranting further evaluation.

Alarm features — gastrointestinal bleedingEvidence of GI bleeding is an alarm feature and may prompt endoscopic assessment.

Alarm features — unexplained iron deficiencyUnexplained iron deficiency (anemia) is an alarm feature indicating possible significant pathology.

Alarm features — weight lossUnintentional weight loss is an alarm feature requiring further diagnostic workup.

83009
83013
83014
86318
86677
87070
87077
87081
87149
87150

OpenPayer

Helicobacter pylori Testing

Coverage Criteria for H. pylori Testing

Procedure and Test Codes

Documentation, Claims, and Review Requirements

Key Definitions